Nanah A, Al Hadidi S. Real-World Use of Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: A Systematic Review. JAPAJ [Internet]. 2023 Jun. 4 [cited 2024 Dec. 22];1(2). Available from: https://journal.japacademy.org/index.php/Home/article/view/56